Progress in the clinical development of CX-2051, targeted at advanced colorectal cancer, with initial Phase 1a clinical data expected in the first half of 2025. CytomX maintains a strong financial ...

CytomX Therapeutics has updated its pipeline priorities for 2025, highlighting its lead program, CX-2051, a first-in-class PROBODY ADC targeting EpCAM for advanced metastatic colorectal cancer, with ...

Customer experience (CX) programs that have been running for several years are often in a Catch-22: the program has lost buy-in because it is not perceived to produce actionable insights; however, ...

Customer experience (CX) programs that exceed management expectations are 2.3 times more likely to have CX efforts in marketing not primarily focused on the path to purchase but on the journey after ...

THE CHALLENGES OF 2022 will create an inflection point for customer experience (CX) programs in 2023—and many will not survive. Last year was a rough one for CX programs as companies lost their focus ...

Survey of 160+ CX decision makers at global enterprises finds customer frustration with automation and chatbots to be top challenge in delivering effective customer service Value-based routing–the ...

Every retail operator is aware that the experience a customer has with their brand affects the likelihood that they will be a repeat customer. Many would argue this is a major aspect of developing ...